Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Biohaven Ltd. (BHVN) Cash Flow Statement

Biohaven Ltd. (BHVN) generated -$511.4M of operating cash flow over the twelve months to 2026-06-30, spent $475000 on capital expenditure and had free cash flow of -$511.9M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BHVNBiohaven Ltd.Follow BHVN — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days
LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-297.7-331.7-582.5-609.4-511.4
Capital expenditure6.13.04.00.7-0.5
Free cash flow-303.8-334.8-586.5-610.2-511.9
Stock-based compensation193.628.872.0112.4—

USD millions · SEC XBRL

Biohaven Ltd. — questions

What is Biohaven Ltd.'s operating cash flow?
-$511.4M over the twelve months to 2026-06-30.
How much does Biohaven Ltd. spend on capital expenditure?
$475000 over the twelve months to 2026-06-30.
What is Biohaven Ltd.'s free cash flow?
-$511.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Biohaven Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.